(Q35770722)

English

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive diseas

scientific article published on 4 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Richard A. Larson

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Koen van Besien

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Federico Innocenti

9

object named as

Federico Innocenti

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Peter H O'Donnell

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Andrew S Artz

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Samir D Undevia

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Rish K Pai

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Paula Del Cerro

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sarah Horowitz

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lucy A Godley

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

John Hart

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Olatoyosi M Odenike

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Wendy Stock

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

4 October 2010

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

51

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

2240-2249

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Review of statistical methodologies used to compare (bio)assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Pharmacogenomic progress in individualized dosing of key drugs for cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Optimal prevention of seizures induced by high-dose busulfan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Therapeutic drug monitoring of busulfan in transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Myleran in chronic myeloid leukaemia; results of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Veno-occlusive disease: cytokines, genetics, and haemostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Parenteral busulfan: is therapeutic monitoring still warranted?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Late onset veno-occlusive disease following high-dose chemotherapy and stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Association of busulfan area under the curve with veno-occlusive disease following BMT.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Chronic granulocytic leukemia: the heterogeneity of stem cell differentiation within a single disease entity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

12 July 2018

Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

A limited sampling strategy for pharmacokinetic directed therapy with intravenous busulfan

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Plasma pharmacokinetics of high-dose oral busulfan in children and adults undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Some practical improvements in the continual reassessment method for phase I studies.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Intraindividual variability in busulfan pharmacokinetics in patients undergoing a bone marrow transplant: assessment of a test dose and first dose strategy

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

High busulfan exposure is associated with worse outcomes in a daily i.v. busulfan and fludarabine allogeneic transplant regimen

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.520773

21 January 2018

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4477684

25 September 2018

Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical modifications of the continual reassessment method for phase I cancer clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of a test dose of intravenous busulfan guide dose modifications to achieve an optimal area under the curve of a single daily dose of intravenous busulfan in children undergoing a reduced-intensity conditioning regimen with hematopoi

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic monitoring of busulfan in hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20919852

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/10428194.2010.520773

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20919852%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35770722&oldid=1818633645"